SCHEMBL2727261

SCHEMBL2727261

CC(C)COC(C)ONC(=O)C=Cc1cccc(CO)c1

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HDAC4 P56524 8/20 0.43
MEF2D Q14814 8/20 0.43
TRPV1 Q8NER1 1/20 0.43
MMP1 P03956 2/20 0.41
MMP2 P08253 2/20 0.41
MMP9 P14780 2/20 0.41
AKR1C3 P42330 1/20 0.41
NOS2 P35228 1/20 0.40
KDM4E B2RXH2 2/20 0.39
ALDH1A1 P00352 2/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2C9 P11712 1/20 0.39
MAPK1 P28482 1/20 0.39
CYP2C19 P33261 1/20 0.39
CYP4F2 P78329 1/20 0.38
CYP4A11 Q02928 1/20 0.38
ACHE P22303 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2727257 1.00 HDAC4 (0.43) HDAC4MEF2DTRPV1MMP1MMP2
SCHEMBL1411065 0.86 SLC6A19 (0.39) HDAC4MEF2DTRPV1MMP1MMP2
SCHEMBL1411066 0.86 SLC6A19 (0.39) HDAC4MEF2DTRPV1MMP1MMP2
SCHEMBL1411170 0.84 TDP1 (0.40) HDAC4MEF2DTRPV1MMP1MMP2
SCHEMBL1411168 0.84 TDP1 (0.40) HDAC4MEF2DTRPV1MMP1MMP2
SCHEMBL3457262 0.79 HDAC4 (0.40) HDAC4MEF2DMMP1MMP2MMP9
SCHEMBL3457267 0.79 HDAC4 (0.40) HDAC4MEF2DMMP1MMP2MMP9
SCHEMBL1411360 0.78 MAOB (0.50) HDAC4MMP1MMP2MMP9ACHE
SCHEMBL1411075 0.78 TAS1R3 (0.40) NOS2ALDH1A1
SCHEMBL1411363 0.78 MAOB (0.50) HDAC4MMP1MMP2MMP9ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012025701-A1 ALPHA, ALPHA - DI SUBSTITUTED GLYCINE ESTER DERIVATIVES AND THEIR USE AS HDAC INHIBITORS CHROMA THERAPEUTICS LTD. (GB) 2012-03-01 WO disclosed